Conmed [CNMD] vs Establishment Labs [ESTA] Detailed Stock Comparison

Conmed Corporation

NYSE
Loading...

Establishment Labs Holdings Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Conmed Corporation wins in 15 metrics, Establishment Labs Holdings Inc. wins in 4 metrics, with 0 ties. Conmed Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Conmed Corporation Establishment Labs Holdings Inc. Better
P/E Ratio (TTM) 25.39 -37.89 Conmed Corporation
Price-to-Book Ratio 1.15 79.68 Conmed Corporation
Debt-to-Equity Ratio 85.91 1,123.15 Conmed Corporation
PEG Ratio -0.50 0.41 Establishment Labs Holdings Inc.
EV/EBITDA 10.06 -70.21 Conmed Corporation
Profit Margin (TTM) 3.42% -24.19% Conmed Corporation
Operating Margin (TTM) 7.25% -6.08% Conmed Corporation
EBITDA Margin (TTM) 7.25% N/A N/A
Return on Equity 4.72% -133.25% Conmed Corporation
Return on Assets (TTM) 3.47% -6.93% Conmed Corporation
Free Cash Flow (TTM) $150.88M $-57.61M Conmed Corporation
Dividend Yield 1.15% N/A N/A
1-Year Return -35.07% 119.39% Establishment Labs Holdings Inc.
Price-to-Sales Ratio (TTM) 0.86 8.92 Conmed Corporation
Enterprise Value $2.03B $2.07B Establishment Labs Holdings Inc.
EV/Revenue Ratio 1.48 9.79 Conmed Corporation
Gross Profit Margin (TTM) 58.49% 70.46% Establishment Labs Holdings Inc.
Revenue per Share (TTM) $44 $7 Conmed Corporation
Earnings per Share (Diluted) $1.51 $-1.72 Conmed Corporation
Beta (Stock Volatility) 0.99 1.08 Conmed Corporation
Short % of Float 9.10% 22.26% Conmed Corporation

Conmed Corporation vs Establishment Labs Holdings Inc. Stock Performance Analysis

Loading Price Chart...

CNMD
ESTA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Conmed Corporation-1.75%-0.96%-3.75%-8.69%-15.28%-15.70%
Establishment Labs Holdings Inc.2.52%12.52%28.06%32.66%16.91%22.33%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Conmed Corporation-35.07%-74.37%-74.32%-19.21%30.57%82.52%
Establishment Labs Holdings Inc.119.39%25.90%5.07%211.25%211.25%211.25%

Performance & Financial Health Analysis: Conmed Corporation vs Establishment Labs Holdings Inc.

MetricCNMDESTA
Market Information
Market Cap i$1.18B$1.91B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i360,290451,437
90 Day Avg. Volume i397,567478,309
Last Close$34.16$84.21
52 Week Range$32.13 - $56.64$33.35 - $86.00
% from 52W High-39.69%-2.08%
All-Time High$159.11 (Nov 01, 2021)$93.80 (Apr 18, 2022)
% from All-Time High-78.53%-10.22%
Growth Metrics
Quarterly Revenue Growth0.08%0.45%
Quarterly Earnings Growth-0.50%0.45%
Financial Health
Profit Margin (TTM) i0.03%-0.24%
Operating Margin (TTM) i0.07%-0.06%
Return on Equity (TTM) i0.05%-1.33%
Debt to Equity (MRQ) i85.911,123.15
Cash & Liquidity
Book Value per Share (MRQ)$33.36$0.80
Cash per Share (MRQ)$1.32$2.58
Operating Cash Flow (TTM) i$170.69M$-50,890,000
Levered Free Cash Flow (TTM) i$169.27M$-41,574,000
Dividends
Last 12-Month Dividend Yield i1.15%N/A
Last 12-Month Dividend i$0.60N/A

Valuation & Enterprise Metrics Analysis: Conmed Corporation vs Establishment Labs Holdings Inc.

MetricCNMD (Apr 26, 2026)ESTA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i25.39-37.89
Forward P/E i7.78316.35
PEG Ratio i-0.500.41
Price to Sales (TTM) i0.868.92
Price to Book (MRQ) i1.1579.68
Market Capitalization
Market Capitalization i$1.18B$1.91B
Enterprise Value i$2.03B$2.07B
Enterprise Value Metrics
Enterprise to Revenue i1.489.79
Enterprise to EBITDA i10.06-70.21
Risk & Other Metrics
Beta i0.991.08
Book Value per Share (MRQ) i$33.36$0.80

Financial Statements Comparison: Conmed Corporation vs Establishment Labs Holdings Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCNMD (2025)ESTA (2025)
Revenue/Sales i1.37B211.08M
Cost of Goods Sold i624.25M64.77M
COGS % of Revenue i45.4%30.7%
Gross Profit i750.48M146.31M
Gross Margin i54.6%69.3%
Research & Development i55.88M20.25M
Operating Income (EBIT) i102.62M-39.01M
Operating Margin i7.5%-18.5%
EBITDA i176.49M-22.29M
EBITDA Margin i12.8%-10.6%
Pre-Tax Income i71.12M-58.02M
Pre-Tax Income % of Revenue i5.2%-27.5%
Income Tax i24.06M-6.96M
Income Tax % of Revenue i1.8%-3.3%
Net Income (Profit) i47.06M-51.06M
Profit Margin i3.4%-24.2%

Balance Sheet & Liquidity Metrics

MetricCNMD (2025)ESTA (2025)
Cash & Equivalents i40.82M75.57M
Total Current Assets i672.86M249.94M
Total Current Assets % of Revenue i48.9%118.4%
Total Current Liabilities i315.04M82.14M
Total Current Liabilities % of Revenue i22.9%38.9%
Long-Term Debt i834.23M250.34M
Long-Term Debt % of Revenue i60.7%118.6%
Total Shareholders Equity i1.03B23.55M
Retained Earnings i588.77M-495.76M
Retained Earnings % of Revenue i42.8%-234.9%
Property, Plant & Equipment i04.34M

Cash Flow Statement Comparison

MetricCNMD (2025)ESTA (2025)
Operating Cash Flow i155.41M-50.78M
Operating Cash Flow % of Revenue i11.3%-24.1%
Capital Expenditures i-19.81M-6.05M
Free Cash Flow i150.88M-57.61M
FCF Margin i11.0%-27.3%
Debt Repayment i-795.25M-1.02M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCNMDESTA
Shares Short i2.31M5.22M
Short Ratio i5.609.90
Short % of Float i9.10%22.26%
Shares Outstanding i30.97M29.30M
Float Shares i30.54M19.22M
% Held by Insiders i0.41%10.16%
% Held by Institutions i113.93%102.08%
% Held by Public i-14.34%-12.24%

Dividend Analysis & Yield Comparison: Conmed Corporation vs Establishment Labs Holdings Inc.

MetricCNMDESTA
Last 12-Month Dividend i$0.60N/A
Last 12-Month Dividend Yield i1.15%N/A
3-Year Avg Annual Dividend i$0.73N/A
3-Year Avg Dividend Yield i0.24%N/A
3-Year Total Dividends i$2.20N/A
Ex-Dividend DateMar 14, 2025N/A